126 related articles for article (PubMed ID: 2187523)
41. The bimanual ovarian palpation examination in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: Performance and complications.
Doroudi M; Kramer BS; Pinsky PF
J Med Screen; 2017 Dec; 24(4):220-222. PubMed ID: 27903809
[TBL] [Abstract][Full Text] [Related]
42. Assessment of symptomatic women for early diagnosis of ovarian cancer: results from the prospective DOvE pilot project.
Gilbert L; Basso O; Sampalis J; Karp I; Martins C; Feng J; Piedimonte S; Quintal L; Ramanakumar AV; Takefman J; Grigorie MS; Artho G; Krishnamurthy S;
Lancet Oncol; 2012 Mar; 13(3):285-91. PubMed ID: 22257524
[TBL] [Abstract][Full Text] [Related]
43. Screening for ovarian cancer: a review.
Pearson VA
Public Health; 1994 Sep; 108(5):367-82. PubMed ID: 7972677
[TBL] [Abstract][Full Text] [Related]
44. Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study.
Rosenthal AN; Fraser LSM; Philpott S; Manchanda R; Burnell M; Badman P; Hadwin R; Rizzuto I; Benjamin E; Singh N; Evans DG; Eccles DM; Ryan A; Liston R; Dawnay A; Ford J; Gunu R; Mackay J; Skates SJ; Menon U; Jacobs IJ;
J Clin Oncol; 2017 May; 35(13):1411-1420. PubMed ID: 28240969
[TBL] [Abstract][Full Text] [Related]
45. Screening for ovarian cancer: the preliminary experience of a familial ovarian cancer center.
Muto MG; Cramer DW; Brown DL; Welch WR; Harlow BL; Xu H; Brucks JP; Tsao SW; Berkowitz RS
Gynecol Oncol; 1993 Oct; 51(1):12-20. PubMed ID: 8244166
[TBL] [Abstract][Full Text] [Related]
46. Screening for ovarian cancer: a pilot randomised controlled trial.
Jacobs IJ; Skates SJ; MacDonald N; Menon U; Rosenthal AN; Davies AP; Woolas R; Jeyarajah AR; Sibley K; Lowe DG; Oram DH
Lancet; 1999 Apr; 353(9160):1207-10. PubMed ID: 10217079
[TBL] [Abstract][Full Text] [Related]
47. A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers.
Kramer BS; Gohagan J; Prorok PC; Smart C
Cancer; 1993 Jan; 71(2 Suppl):589-93. PubMed ID: 8420681
[TBL] [Abstract][Full Text] [Related]
48. [Screening for ovarian cancers: critical analysis].
Pennehouat G; Gugliemina JN; Naouri M; Créquat J; Bouret JM; Thébault Y; Madelenat P
Contracept Fertil Sex; 1993 Mar; 21(3):223-30. PubMed ID: 7951617
[TBL] [Abstract][Full Text] [Related]
49. How to decrease false-positive cases of ovarian cancer screening by transvaginal sonography.
Misawa T; Asai M; Higashide K
J Exp Clin Cancer Res; 1997 Jun; 16(2):217-20. PubMed ID: 9261750
[TBL] [Abstract][Full Text] [Related]
50. The use of transvaginal sonography for evaluation of postmenopausal ovarian size and morphology.
Rodriguez MH; Platt LD; Medearis AL; Lacarra M; Lobo RA
Am J Obstet Gynecol; 1988 Oct; 159(4):810-4. PubMed ID: 3052076
[TBL] [Abstract][Full Text] [Related]
51. The performance of screening tests for ovarian cancer: results of a systematic review.
Bell R; Petticrew M; Sheldon T
Br J Obstet Gynaecol; 1998 Nov; 105(11):1136-47. PubMed ID: 9853761
[TBL] [Abstract][Full Text] [Related]
52. Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system.
Stirling D; Evans DG; Pichert G; Shenton A; Kirk EN; Rimmer S; Steel CM; Lawson S; Busby-Earle RM; Walker J; Lalloo FI; Eccles DM; Lucassen AM; Porteous ME
J Clin Oncol; 2005 Aug; 23(24):5588-96. PubMed ID: 16110018
[TBL] [Abstract][Full Text] [Related]
53. A comprehensive look at the early detection of ovarian cancer.
O'Rourke J; Mahon SM
Clin J Oncol Nurs; 2003; 7(1):41-7. PubMed ID: 12629933
[TBL] [Abstract][Full Text] [Related]
54. The effectiveness of ovarian cancer screening. A decision analysis model.
Schapira MM; Matchar DB; Young MJ
Ann Intern Med; 1993 Jun; 118(11):838-43. PubMed ID: 8480957
[TBL] [Abstract][Full Text] [Related]
55. Screening for early ovarian cancer.
Bourne TH; Hampson J; Reynolds K; Collins WP; Campbell S
Br J Hosp Med; 1992 Oct 21-Nov 3; 48(8):454-9. PubMed ID: 1422556
[TBL] [Abstract][Full Text] [Related]
56. Cancer screening and risk-reducing behaviors of women seeking genetic cancer risk assessment for breast and ovarian cancers.
MacDonald DJ; Sarna L; Uman GC; Grant M; Weitzel JN
Oncol Nurs Forum; 2006 Nov; 33(2):E27-35. PubMed ID: 16518435
[TBL] [Abstract][Full Text] [Related]
57. [The role of transvaginal ultrasonography in the screening of ovarian tumors].
De Rosa G; Catalano D; Dell'Isola A; Sarnataro C; Cerrone M
Minerva Ginecol; 1997 Jun; 49(6):243-9. PubMed ID: 9289662
[TBL] [Abstract][Full Text] [Related]
58. Ultrasound assessment of ovarian cancer risk in postmenopausal women with CA125 elevation.
Menon U; Talaat A; Jeyarajah AR; Rosenthal AN; MacDonald ND; Skates SJ; Sibley K; Oram DH; Jacobs IJ
Br J Cancer; 1999 Jul; 80(10):1644-7. PubMed ID: 10408412
[TBL] [Abstract][Full Text] [Related]
59. CA 125 as a screening test for ovarian cancer.
Hakama M; Stenman UH; Knekt P; Järvisalo J; Hakulinen T; Maatela J; Aromaa A
J Med Screen; 1996; 3(1):40-2. PubMed ID: 8861050
[TBL] [Abstract][Full Text] [Related]
60. Prospective study using the risk of ovarian cancer algorithm to screen for ovarian cancer.
Menon U; Skates SJ; Lewis S; Rosenthal AN; Rufford B; Sibley K; Macdonald N; Dawnay A; Jeyarajah A; Bast RC; Oram D; Jacobs IJ
J Clin Oncol; 2005 Nov; 23(31):7919-26. PubMed ID: 16258091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
